Clinical Trial

Cardiac Imaging in Systemic Disorders: the ORACLES Registry

Study acronym: ORACLES
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Autoimmune diseases affect a total of 5 to 10% of the population. These diseases are associated with an increased risk of developing cardiovascular pathologies. Modern cardiac imaging tools could provide a better understanding of these complications, enabling earlier diagnosis and detection of patients most at risk. Yet, the diagnostic and prognostic value of multimodal cardiac imaging in these diseases is under-researched. The current registry aimed at investigating the diagnostic and prognostic value of cardiac imaging in autoimmune and systemic disorders.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-19.
Trial Details
NCT Number NCT07134166
Lead Sponsor Assistance Publique - Hôpitaux de Paris
Conditions Lupus
Enrollment 1,500 participants
Start Date 2026-11
Primary Completion 2046-11 (estimated)
Study Completion 2046-11 (estimated)
Updated on ClinicalTrials.gov 2026-02-13